Amid the FDA’s evolving guidance, the plant biotechnology company, which has long focused on the tobacco industry, has expanded to the cannabis space to create commercially desirable cultivars.
Amid the FDA’s evolving guidance, the plant biotechnology company, which has long focused on the tobacco industry, has expanded to the cannabis space to create commercially desirable cultivars.